- Last edited on December 30, 2021
Differences
This shows you the differences between two versions of the page.
|
cognitive-testing:fab [on May 20, 2019] |
cognitive-testing:fab [on March 23, 2020] |
||
|---|---|---|---|
| Line 10: | Line 10: | ||
| ==== Indications ==== | ==== Indications ==== | ||
| Although the FAB was designed for screening for frontotemporal dementia, it has also been used in other clinical settings, including frontal lobe dysfunction in schizophrenia,[([[https://www.europsy-journal.com/article/S0924-9338(07)00425-7/abstract|Nimatoudis, I., Spyridi, S., Kantartzis, S., Sokolaki, S., Panagiotidis, P., Nassika, Z., & Kaprinis, G. (2007). The frontal assessment battery at bedside (FAB) in patients with schizophrenia. European Psychiatry, 22, S128.]])] executive dysfunction screen in Parkinson’s,[([[https://www.ncbi.nlm.nih.gov/pubmed/18821046|Lima, C. F., Meireles, L. P., Fonseca, R., Castro, S. L., & Garrett, C. (2008). The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. Journal of neurology, 255(11), 1756-1761.]])] and executive cognitive dysfunction in substance dependence.[([[https://www.ncbi.nlm.nih.gov/pubmed/20584570|Cunha, P. J., Nicastri, S., de Andrade, A. G., & Bolla, K. I. (2010). The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility. Addictive behaviors, 35(10), 875-881.]])] It can provide an objective measure to distinguish FTD from AD in mildly demented patients.[([[http://jamanetwork.com/journals/jamaneurology/fullarticle/786118|Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B. Frontal Assessment Battery and Differential Diagnosis of Frontotemporal Dementia and Alzheimer Disease. Arch Neurol. 2004;61(7):1104–1107.]])] | Although the FAB was designed for screening for frontotemporal dementia, it has also been used in other clinical settings, including frontal lobe dysfunction in schizophrenia,[([[https://www.europsy-journal.com/article/S0924-9338(07)00425-7/abstract|Nimatoudis, I., Spyridi, S., Kantartzis, S., Sokolaki, S., Panagiotidis, P., Nassika, Z., & Kaprinis, G. (2007). The frontal assessment battery at bedside (FAB) in patients with schizophrenia. European Psychiatry, 22, S128.]])] executive dysfunction screen in Parkinson’s,[([[https://www.ncbi.nlm.nih.gov/pubmed/18821046|Lima, C. F., Meireles, L. P., Fonseca, R., Castro, S. L., & Garrett, C. (2008). The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. Journal of neurology, 255(11), 1756-1761.]])] and executive cognitive dysfunction in substance dependence.[([[https://www.ncbi.nlm.nih.gov/pubmed/20584570|Cunha, P. J., Nicastri, S., de Andrade, A. G., & Bolla, K. I. (2010). The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility. Addictive behaviors, 35(10), 875-881.]])] It can provide an objective measure to distinguish FTD from AD in mildly demented patients.[([[http://jamanetwork.com/journals/jamaneurology/fullarticle/786118|Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B. Frontal Assessment Battery and Differential Diagnosis of Frontotemporal Dementia and Alzheimer Disease. Arch Neurol. 2004;61(7):1104–1107.]])] | ||
| + | |||
| <HTML> | <HTML> | ||
| - | <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> | + | <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> |
| + | <!-- Leaderboard --> | ||
| <ins class="adsbygoogle" | <ins class="adsbygoogle" | ||
| - | style="display:block; text-align:center;" | + | style="display:block" |
| - | data-ad-layout="in-article" | + | |
| - | data-ad-format="fluid" | + | |
| data-ad-client="ca-pub-8020066590182443" | data-ad-client="ca-pub-8020066590182443" | ||
| - | data-ad-slot="2205743206"></ins> | + | data-ad-slot="1227446251" |
| + | data-ad-format="auto"></ins> | ||
| <script> | <script> | ||
| (adsbygoogle = window.adsbygoogle || []).push({}); | (adsbygoogle = window.adsbygoogle || []).push({}); | ||
| </script> | </script> | ||
| </HTML> | </HTML> | ||
| + | |||
| ===== Components and Scoring ===== | ===== Components and Scoring ===== | ||
| ==== Similarities ==== | ==== Similarities ==== | ||
| Line 115: | Line 117: | ||
| </WRAP> | </WRAP> | ||
| </WRAP> | </WRAP> | ||
| + | |||
| <HTML> | <HTML> | ||
| - | <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> | + | <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> |
| + | <!-- Leaderboard --> | ||
| <ins class="adsbygoogle" | <ins class="adsbygoogle" | ||
| - | style="display:block; text-align:center;" | + | style="display:block" |
| - | data-ad-layout="in-article" | + | |
| - | data-ad-format="fluid" | + | |
| data-ad-client="ca-pub-8020066590182443" | data-ad-client="ca-pub-8020066590182443" | ||
| - | data-ad-slot="3544422091"></ins> | + | data-ad-slot="1227446251" |
| + | data-ad-format="auto"></ins> | ||
| <script> | <script> | ||
| (adsbygoogle = window.adsbygoogle || []).push({}); | (adsbygoogle = window.adsbygoogle || []).push({}); | ||